Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-12T21:38:11.442Z Has data issue: false hasContentIssue false
  • English
  • Français

Discrepancy between objective weight gain and recognition as a side effect of anti-psychotic treatment

Published online by Cambridge University Press:  16 April 2020

E.M. Haberfellner  and
H. Rittmannsberger
E.M. Haberfellner
Affiliation:
Psychiatrist in private practice, Friedrichstrae 14, 4040Linz, Austria
H. Rittmannsberger
Affiliation:
OÖ Landesnervenklinik Wagner-Jauregg-Weg 15, 4020Linz, Austria

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letter to the editor
Information
European Psychiatry , Volume 14 , Issue 5 , September 1999 , pp. 298
Copyright
Copyright © 1999 Éditions scientifiques et médicales Elsevier SAS.

References

Bollini, PPampallona, SOrza, MJAdams, MEChalmers, TC. Anti-psychotic drugs: is more worse? A meta-analysis of the published randomized control trials. Psychol Med 1994; 24: 307–316CrossRefGoogle Scholar
Fleischhacker, WWMeise, UGünther, VKurz, M. Compliance with anti-psychotic drug treatment: influence of sideeffects. Acta Psychiatr Scand 1994; 89 Suppl 382: 11–15Google Scholar
Pach, JOsterheider, MFinkbeiner, TGreger, JHaug, HJStrobl, R. Differential dosage of flupenthixol–decanoate for relapse prevention in schizophrenic patients – Results of the MARS study. Psychopharmakotherapie 1998; 5: 150–155Google Scholar
Stanton, J. Weight gain associated with neuroleptic medication: a review. Schizophr Bull 1995; 21: 463–472CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.